Disalcid label

Disalcid

Disalcid Recall

Get an alert when a recall is issued.

Add Info

Side Effects & Adverse Reactions

Reye’s Syndrome may develop in individuals who have chicken pox, influenza, or flu symptoms. Some studies suggest a possible association between the development of Reye’s Syndrome and the use of medicines containing salicylate or aspirin. Salsalate contains a salicylate and therefore is not recommended for  use in patients with chicken pox, influenza, or flu symptoms.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

Carefully consider the potential benefits and risks of DISALCID (Salsalate) TABLETS and other treatment options before deciding to use DISALCID (Salsalate) TABLETS. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS). Salsalate is indicated for relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorder.

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

DISALCID (Salsalate) TABLETS contain the active ingredient Salsalate, which is a nonsteroidal anti-inflammatory agent for oral administration. Chemically, salsalate (salicylsalicylic acid or 2-hydroxy-benzoic acid, 2-carboxyphenyl ester) is a dimer of salicylic acid; its structural formula is shown below.

Chemical Structure:

ChemStruc

Inactive Ingredients: Hydroxypropylmethyl Cellulose, Magnesium Stearate, Microcrystalline Cellulose, Polyethylene Glycol.

Add Info
Add to My Alerts
Report Side Effect
Leave a Review
Navigate to :
Disalcid Recall
Side Effects & Adverse Reactions
Legal Issues
FDA Safety Alerts
Manufacturer Warnings
FDA Labeling Changes
Uses
History
Other Information
Manufacturers
Trending Topics

Disalcid Manufacturers

  • Avion Pharmaceuticals, Llc
    Disalcid | Avion Pharmaceuticals, Llc
    No Recall

    Disalcid | Avion Pharmaceuticals, Llc

    Disalcid | Avion Pharmaceuticals, Llc

    Carefully consider the potential benefits and risks of DISALCID (Salsalate) TABLETS and other treatment options before deciding to use DISALCID (Salsalate) TABLETS. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS).

    After observing the response to initial therapy with DISALCID (Salsalate) TABLETS, the dose and frequency should be adjusted to suit an individual patient's needs. Salsalate is indicated for relief of the signs and symptoms of rheumatoid arthritis, osteoarthritis and related rheumatic disorder.

    Adults: The usual dosage is 3000 mg daily, given in divided doses as follows:

    1) two doses of two 750 mg tablets; 2) two doses of three 500 mg tablets; or 3) three doses of two 500 mg tablets. Some patients, e.g., the elderly, may require a lower dosage to achieve therapeutic blood concentrations and to avoid the more common side effects such as auditory.

    Alleviation of symptoms is gradual, and full benefit may not be evident for 3 to 4 days, when plasma salicylate levels have achieved steady state. There is no evidence for development of tissue tolerance (tachyphylaxis), but salicylate therapy may induce increased activity of metabolizing liver enzymes, causing a greater rate of salicyluric acid production and excretion, with a resultant increase in dosage requirement for maintenance of therapeutic serum salicylate levels.

    Children: Dosage recommendations and indications for salsalate use in children have not been established.

Login To Your Free Account